The US Food and Drug Administration (FDA) is requiring manufacturers of GLP-1 medicines to update their safety labels to warn of a potential increased risk of a rare but serious eye condition that can cause permanent vision loss.
Today's highlights
🌏 Regional Digest
🏷️ Topic Digest
🗞️ Latest news by region
Loading...
